Pre-exposure (PrEP)
Pre-exposure Prophylaxis (PrEP)
AIDS 2012: HIV PrEP: Toxic Lifelong Therapy or Effective Niche Prevention? [VIDEO]
- Details
- Category: HIV Prevention
- Published on Wednesday, 01 August 2012 00:00
- Written by Gregory Fowler
Pre-exposure prophylaxis -- better known as PrEP -- for HIV prevention remains a controversial issue. At the XIX International AIDS Conference (AIDS 2012) last week in Washington, DC, Julio Montaner and Kenneth Mayer described new IAPAC PrEP guidelines and responded to concerns of a skeptical journalist.
AIDS 2012: Nick Rhoades -- Criminal Transmission of HIV [VIDEO]
- Details
- Category: HIV Prevention
- Published on Wednesday, 01 August 2012 00:00
- Written by Gregory Fowler
In 2008 Nick Rhoades was convicted of "Criminal Transmission of HIV" in Iowa, even though his viral load was undetectable, he used a condom, and his accuser did not contract HIV. He told his story at a press conference at the XIX International AIDS Conference (AIDS 2012) last week in Washington, DC.
FDA Approves Truvada PrEP for Prevention of Sexually Transmitted HIV Infection
- Details
- Category: HIV Prevention
- Published on Monday, 16 July 2012 00:00
- Written by Liz Highleyman
On July 16, 2012, the U.S. Food and Drug Administration (FDA) approved Truvada -- Gilead Sciences' tenofovir/emtricitabine combination pill -- for pre-exposure prophylaxis (PrEP) to prevent sexual transmission of HIV.
NEXT-PrEP Trial Will Test CCR5 Blocker Maraviroc for HIV Prevention
- Details
- Category: HIV Prevention
- Published on Friday, 20 July 2012 00:00
- Written by Press Release
The National Institutes of Health (NIH) this week announced a new clinical trial to assess whether taking the CCR5 antagonist maraviroc (Selzentry) daily -- alone or with other antiretroviral drugs -- can help lower the risk of HIV infection.
HIV PrEP Can Be Highly Effective, but Only if Used Consistently
- Details
- Category: HIV Prevention
- Published on Friday, 13 July 2012 00:00
- Written by Liz Highleyman
Pre-exposure prophylaxis (PrEP) with tenofovir or Truvada can dramatically lower the risk of HIV sexual transmission for heterosexual men and women -- as has previously been shown for gay men -- but good adherence is crucial to its success, according to a trio of studies published in the July 11, 2012, advance online edition of the New England Journal of Medicine.
Web Design and Development by